Terms: = Prostate cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1
19 results:
1. Apolipoprotein B mRNA-Editing Catalytic Polypeptide-Like-Induced Protein Changes in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast cancer Throughout Disease Progression.
Bos MK; Smid M; Sleijfer S; Martens JWM
JCO Precis Oncol; 2022 Jan; 6():e2100190. PubMed ID: 35050709
[TBL] [Abstract] [Full Text] [Related]
2. map3k1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.
Xue Z; Vis DJ; Bruna A; Sustic T; van Wageningen S; Batra AS; Rueda OM; Bosdriesz E; Caldas C; Wessels LFA; Bernards R
Cell Res; 2018 Jul; 28(7):719-729. PubMed ID: 29795445
[TBL] [Abstract] [Full Text] [Related]
3. A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast cancer Cells.
Reineri S; Agati S; Miano V; Sani M; Berchialla P; Ricci L; Iannello A; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
PLoS One; 2016; 11(12):e0168639. PubMed ID: 27992601
[TBL] [Abstract] [Full Text] [Related]
4. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.
Mochamat ; Cuhls H; Marinova M; Kaasa S; Stieber C; Conrad R; Radbruch L; Mücke M
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):25-39. PubMed ID: 27897391
[TBL] [Abstract] [Full Text] [Related]
5. The Accomplices of NF-κB Lead to Radioresistance.
Bai M; Ma X; Li X; Wang X; Mei Q; Li X; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):279-94. PubMed ID: 25929862
[TBL] [Abstract] [Full Text] [Related]
6. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
Qiu Z; Zhou B; Jin L; Yu H; Liu L; Liu Y; Qin C; Xie S; Zhu F
Food Chem Toxicol; 2013 Sep; 59():428-37. PubMed ID: 23811531
[TBL] [Abstract] [Full Text] [Related]
7. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract] [Full Text] [Related]
8. prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
[TBL] [Abstract] [Full Text] [Related]
9. Differential activation of the JNK signal pathway by UV irradiation and glucose deprivation.
Song JJ; Lee YJ
Cell Signal; 2007 Mar; 19(3):563-72. PubMed ID: 17029735
[TBL] [Abstract] [Full Text] [Related]
10. The antitumor efficacy of calcitriol: preclinical studies.
Johnson CS; Muindi JR; Hershberger PA; Trump DL
Anticancer Res; 2006; 26(4A):2543-9. PubMed ID: 16886662
[TBL] [Abstract] [Full Text] [Related]
11. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.
Zhu P; Baek SH; Bourk EM; Ohgi KA; Garcia-Bassets I; Sanjo H; Akira S; Kotol PF; Glass CK; Rosenfeld MG; Rose DW
Cell; 2006 Feb; 124(3):615-29. PubMed ID: 16469706
[TBL] [Abstract] [Full Text] [Related]
12. Oxidative stress inhibits mekk1 by site-specific glutathionylation in the ATP-binding domain.
Cross JV; Templeton DJ
Biochem J; 2004 Aug; 381(Pt 3):675-83. PubMed ID: 15139849
[TBL] [Abstract] [Full Text] [Related]
13. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Kishi M; Konishi N
Carcinogenesis; 2004 Jul; 25(7):1089-97. PubMed ID: 15001534
[TBL] [Abstract] [Full Text] [Related]
14. Vitamin D-related therapies in prostate cancer.
Johnson CS; Hershberger PA; Trump DL
Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
[TBL] [Abstract] [Full Text] [Related]
15. Androgen receptor acetylation governs trans activation and mekk1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.
Fu M; Wang C; Wang J; Zhang X; Sakamaki T; Yeung YG; Chang C; Hopp T; Fuqua SA; Jaffray E; Hay RT; Palvimo JJ; Jänne OA; Pestell RG
Mol Cell Biol; 2002 May; 22(10):3373-88. PubMed ID: 11971970
[TBL] [Abstract] [Full Text] [Related]
16. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor.
Kraus S; Naor Z; Seger R
Arch Med Res; 2001; 32(6):499-509. PubMed ID: 11750725
[TBL] [Abstract] [Full Text] [Related]
17. Human DU145 prostate cancer cells overexpressing mitogen-activated protein kinase phosphatase-1 are resistant to Fas ligand-induced mitochondrial perturbations and cellular apoptosis.
Srikanth S; Franklin CC; Duke RC; Kraft RS
Mol Cell Biochem; 1999 Sep; 199(1-2):169-78. PubMed ID: 10544965
[TBL] [Abstract] [Full Text] [Related]
18. Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer.
Abreu-Martin MT; Chari A; Palladino AA; Craft NA; Sawyers CL
Mol Cell Biol; 1999 Jul; 19(7):5143-54. PubMed ID: 10373563
[TBL] [Abstract] [Full Text] [Related]
19. cancer incidence rates among Japanese immigrants in the city of São Paulo, Brazil, 1969-78.
Tsugane S; de Souza JM; Costa ML; Mirra AP; Gotlieb SL; Laurenti R; Watanabe S
Cancer Causes Control; 1990 Sep; 1(2):189-93. PubMed ID: 2102290
[TBL] [Abstract] [Full Text] [Related]
